NanoMosaic
Waltham
About NanoMosaic
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification. Its protein interrogation powered by nanoneedles enables early disease detection, and prognostic monitoring. .
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $44.8M
- Last round: Series Unknown (Nov 2025)
- Website: nanomosaicllc.com
- Phone: +1 617-925-7771
Industries & Categories
Biopharma, Biotechnology, Genetics, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nanomosaic-78613 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.